Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of -71.42 is 7857% below its 5-year average of 0.92, around the middle of its 5-year range (-152.97–4.70).
As of the fiscal period ended Friday, July 31, 2026. 0.45% below its 12-month average of -71.10.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2027 (2026-07-31): -71.42.
QUICK RATIO (ACID-TEST)
-71.42
QUICK RATIO (ACID-TEST) AVG TTM
-71.10
QUICK RATIO (ACID-TEST) AVG 3Y
1.66
QUICK RATIO (ACID-TEST) AVG 5Y
0.92
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.45%
CURRENT VS 3Y AVG
-4410.12%
CURRENT VS 5Y AVG
-7857.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 564 covered companies
CURRENT VS SECTOR MEDIAN
-2488.60%
vs the sector median at left
HeartSciences Inc.
Market Cap
$7.34M
Quick Ratio (Acid-Test)
-71.42
TTM Avg
-71.10
3Y Avg
1.66
5Y Avg
0.92
Market Cap
$7.37M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$7.46M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
Market Cap
$7.17M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.09M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
Market Cap
$7.07M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$7.83M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$6.82M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $7.34M | -71.42 | -71.10 | 1.66 | 0.92 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.37M | 1.37 | 3.92 | 4.12 | 3.73 |
| Longeveron Inc. (LGVN)vs › | $7.46M | 2.63 | 4.46 | 3.65 | 4.69 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.17M | 45.95 | 58.73 | 40.89 | 40.89 |
| KALA BIO, Inc. (KALA)vs › | $7.10M | 6.88 | 3.46 | 4.15 | 4.53 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.09M | 0.18 | 0.90 | 2.06 | 1.76 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | 1.52 | 3.93 | 10.24 | 10.80 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | 5.86 | 2.71 | 2.06 | 3.31 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | 2.61 | 3.40 | 4.86 | 5.09 |
| Aclarion, Inc. (ACON)vs › | $6.80M | 16.20 | 7.76 | 4.60 | 3.08 |
Quick Ratio
-71.42
Excludes inventory
Current Ratio
0.12
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | -71.42 |
| 2026-04-30 | -134.37 |
| 2026-01-31 | -152.97 |
| 2025-10-31 | 2.00 |
| 2025-07-31 | 1.25 |
| 2025-04-30 | 0.41 |
| 2025-01-31 | 0.83 |
| 2024-10-31 | 1.52 |
| 2024-07-31 | 4.02 |
| 2024-04-30 | 3.84 |
| 2024-01-31 | 4.70 |
| 2023-10-31 | 0.32 |
| 2023-07-31 | 0.71 |
| 2023-04-30 | 1.10 |
| 2023-01-31 | 1.10 |
| 2022-10-31 | 1.10 |
| 2022-07-31 | 3.09 |
| 2022-04-30 | 0.36 |
| 2022-01-31 | 0.00 |
| 2021-10-31 | 0.00 |
| 2021-07-31 | 0.00 |
| 2021-04-30 | 0.80 |
